An Accurate and Interpretable Bayesian Classification Model for Prediction of hERG Liability
暂无分享,去创建一个
[1] Cavero,et al. QT interval prolongation by non-cardiovascular drugs: issues and solutions for novel drug development. , 1999, Pharmaceutical science & technology today.
[2] Jun Chen,et al. A structural basis for drug-induced long QT syndrome. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[3] F. Ashcroft,et al. Crystal Structure of the Potassium Channel KirBac1.1 in the Closed State , 2003, Science.
[4] J. Berger. Statistical Decision Theory and Bayesian Analysis , 1988 .
[5] Roy J. Vaz,et al. Characterization of HERG potassium channel inhibition using CoMSiA 3D QSAR and homology modeling approaches. , 2003, Bioorganic & medicinal chemistry letters.
[6] Hongmao Sun. A naive bayes classifier for prediction of multidrug resistance reversal activity on the basis of atom typing. , 2005, Journal of medicinal chemistry.
[7] J. Li,et al. A two-state homology model of the hERG K+ channel: application to ligand binding. , 2005, Bioorganic & medicinal chemistry letters.
[8] Bernd Wollnik,et al. The antihistamine fexofenadine does not affect IKr currents in a case report of drug‐induced cardiac arrhythmia , 2002, British journal of pharmacology.
[9] M. Cadene,et al. X-ray structure of a voltage-dependent K+ channel , 2003, Nature.
[10] Gisbert Schneider,et al. A Virtual Screening Method for Prediction of the hERG Potassium Channel Liability of Compound Libraries , 2002, Chembiochem : a European journal of chemical biology.
[11] R. MacKinnon,et al. Structure of the cytoplasmic beta subunit-T1 assembly of voltage-dependent K+ channels. , 2000, Science.
[12] G. Keserü. Prediction of hERG potassium channel affinity by traditional and hologram qSAR methods. , 2003, Bioorganic & medicinal chemistry letters.
[13] W. Crumb,et al. Three-dimensional quantitative structure-activity relationship for inhibition of human ether-a-go-go-related gene potassium channel. , 2002, The Journal of pharmacology and experimental therapeutics.
[14] Anthony E. Klon,et al. Finding more needles in the haystack: A simple and efficient method for improving high-throughput docking results. , 2004, Journal of medicinal chemistry.
[15] Michael C Sanguinetti,et al. Voltage-dependent profile of human ether-a-go-go-related gene channel block is influenced by a single residue in the S6 transmembrane domain. , 2003, Molecular pharmacology.
[16] Thomas J. Watson,et al. An empirical study of the naive Bayes classifier , 2001 .
[17] Andreas Bender,et al. Molecular Similarity Searching Using Atom Environments, Information-Based Feature Selection, and a Naïve Bayesian Classifier , 2004, J. Chem. Inf. Model..
[18] B. Fermini,et al. The impact of drug-induced QT interval prolongation on drug discovery and development , 2003, Nature Reviews Drug Discovery.
[19] A. Cavalli,et al. QT prolongation through hERG K+ channel blockade: Current knowledge and strategies for the early prediction during drug development , 2005, Medicinal research reviews.
[20] Xiaoyang Xia,et al. Classification of kinase inhibitors using a Bayesian model. , 2004, Journal of medicinal chemistry.
[21] Pedro M. Domingos,et al. On the Optimality of the Simple Bayesian Classifier under Zero-One Loss , 1997, Machine Learning.
[22] Youxing Jiang,et al. Structure of the RCK Domain from the E. coli K+ Channel and Demonstration of Its Presence in the Human BK Channel , 2001, Neuron.
[23] Hongmao Sun,et al. A Universal Molecular Descriptor System for Prediction of LogP, LogS, LogBB, and Absorption , 2004, J. Chem. Inf. Model..
[24] Maurizio Recanatini,et al. Safety of Non-Antiarrhythmic Drugs that Prolong the QT Interval or Induce Torsade de Pointes , 2002, Drug safety.
[25] Hongmao Sun. Predicting ADMET Properties by Projecting onto Chemical Space?Benefits and Pitfalls , 2005 .
[26] Gary Yellen,et al. The inward rectification mechanism of the HERG cardiac potassium channel , 1996, Nature.
[27] Robert Pearlstein,et al. Understanding the structure-activity relationship of the human ether-a-go-go-related gene cardiac K+ channel. A model for bad behavior. , 2003, Journal of medicinal chemistry.
[28] A. Camm,et al. Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development. , 2003, Cardiovascular research.
[29] A. Cavalli,et al. Toward a pharmacophore for drugs inducing the long QT syndrome: insights from a CoMFA study of HERG K(+) channel blockers. , 2002, Journal of medicinal chemistry.
[30] Jürgen Bajorath,et al. Combinatorial Preferences Affect Molecular Similarity/Diversity Calculations Using Binary Fingerprints and Tanimoto Coefficients , 2000, J. Chem. Inf. Comput. Sci..